Literatur
-
1
ALLHAT Officers and Coordinators for ALLHAT .
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blockers vs diuretics: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
JAMA.
2002;
288
2981-2997
-
2
Chobanian A V, Bakris G L, Black H R, Cushman W C. et al .
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report.
JAMA.
2003;
289
2560-2571
-
3
Neal B, MacMahon S, Chapman N. for the Blood Pressure Lowering Treatment Trialist’s Collaboration .
Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs: results of prospectively designed overviews of randomised trials.
Lancet.
2000;
356
1955-1964
-
4
Wing L MH, Reid M C, Ryan P, Beilin L J. et al. for the Second Australian National Blood Pressure Study Group .
A comparison of outcomes with angiotensin converting enzyme inhibitors and diuretics for hypertension in the elderly.
NEJM.
2003;
348
583-592
-
5
Dahlöf B, Devereux R B, Kjeldsen S E, Julius S. et al .
Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE): a randomised trial against atenolol.
Lancet.
2002;
359
995-1003
-
6
Liebl A, Neiss A, Spannheimer A, Reitberger U, Wagner T, Gorth A.
Costs of type 2 diabetes in Germany. Results of the CODE-2 study.
Dtsch Med Wochenschr.
2001;
18
585-589
-
7
Mogensen C E, Viberti G, Halimi S, Ritz E. et al .
Effect of low-dose perindopril/indapamide on albuminuria: preterax in albuminuria regression.
Premier Hypertension.
2003;
41
1063-1071
-
8
De Leeuw P W, Birkenhager W H.
Treating hypertension is more important than the choice of agent: results from the largest clinical trial until now.
Ned Tijdschr Geneeskd.
2003;
12
685-689
Prof. Dr. Dr. h. c. mult. Eberhard Ritz
Medizinische Universitätsklinik Heidelberg
Bergheimer Straße 56a
69115 Heidelberg
